Hillstream BioPharma Terminates Agreement with Intract Pharma Ltd, Appoints New Board MemberWASHINGTON, D.C. — On November 20, 2024, Tharimmune, Inc., with its principal executive offices located in Bridgewater, New Jersey, filed a Form 8-K with the
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Hillstream BioPharma’s 8K filing here. About Hillstream BioPharma (Get Free Report) Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell […]
More Stories
Korro Bio, Inc. (NASDAQ:KRRO) Receives $142.17 Average Price Target from Brokerages
Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings...
TD Securities Cuts Talon Metals (TSE:TLO) Price Target to C$0.30
Talon Metals (TSE:TLO – Free Report) had its price target decreased by TD Securities from C$0.55 to C$0.30 in a...
Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a report published on Monday morning....
Reading International (NASDAQ:RDI) Now Covered by StockNews.com
StockNews.com began coverage on shares of Reading International (NASDAQ:RDI – Free Report) in a report issued on Monday. The firm...
Symbolic Logic (NASDAQ:EVOL) Now Covered by StockNews.com
StockNews.com started coverage on shares of Symbolic Logic (NASDAQ:EVOL – Free Report) in a research report sent to investors on...
Remark (NASDAQ:MARK) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Remark (NASDAQ:MARK – Free Report) in a research report released on Monday. The firm...